C07D 275/03
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D275/03 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 461 US grants and 274 published applications in this corpus.
Search patents in C07D- Granted patents
- 461
- Published applications
- 274
- Assignees
- 226
- Inventors
- 1,272
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 19 | 0 |
| 1978 | 9 | 0 |
| 1979 | 16 | 0 |
| 1980 | 12 | 0 |
| 1981 | 17 | 0 |
| 1982 | 6 | 0 |
| 1983 | 6 | 0 |
| 1984 | 3 | 0 |
| 1985 | 6 | 0 |
| 1986 | 4 | 0 |
| 1987 | 5 | 0 |
| 1988 | 4 | 0 |
| 1989 | 8 | 0 |
| 1990 | 16 | 0 |
| 1991 | 10 | 0 |
| 1992 | 15 | 0 |
| 1993 | 11 | 0 |
| 1994 | 15 | 0 |
| 1995 | 12 | 0 |
| 1996 | 14 | 0 |
| 1997 | 8 | 0 |
| 1998 | 10 | 0 |
| 1999 | 12 | 0 |
| 2000 | 5 | 0 |
| 2001 | 10 | 1 |
| 2002 | 12 | 5 |
| 2003 | 8 | 10 |
| 2004 | 9 | 18 |
| 2005 | 7 | 10 |
| 2006 | 6 | 16 |
| 2007 | 7 | 8 |
| 2008 | 11 | 16 |
| 2009 | 5 | 15 |
| 2010 | 15 | 17 |
| 2011 | 10 | 11 |
| 2012 | 12 | 12 |
| 2013 | 11 | 14 |
| 2014 | 12 | 10 |
| 2015 | 11 | 10 |
| 2016 | 8 | 6 |
| 2017 | 6 | 7 |
| 2018 | 7 | 12 |
| 2019 | 11 | 12 |
| 2020 | 7 | 9 |
| 2021 | 8 | 15 |
| 2022 | 8 | 10 |
| 2023 | 4 | 10 |
| 2024 | 2 | 13 |
| 2025 | 1 | 5 |
| 2026 | 5 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Inhibitors of SARM112 May 2026US 12,624,025 B2Disarm Therapeutics, Inc.
- Inhibitors of SARM112 May 2026US 12,624,026 B2Disarm Therapeutics, Inc.
- Methods and materials for inhibiting NF-kB activity21 Apr 2026US 12,606,528 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Inhibiting USP3631 Mar 2026US 12,590,087 B2Valo Health, Inc.
- Protein tyrosine kinase inhibitor and medical use thereof30 Jul 2026US 2026/0217698 A1Beyang Therapeutics Co., Ltd.
- Isothiazolylcarboxamide compounds and their use in therapy7 May 2026US 2026/0124222 A1Hotspot Therapeutics, Inc.
- Dichlorophenol hsd17b13 inhibitors and uses thereof11 Dec 2025US 2025/0376457 A1Inipharm, Inc.
- Inhibitors of Molluscum Contagiosum Infection and Methods Using the Same25 Sep 2025US 2025/0295652 A1The Trustees of the University of Pennsylvania
- Anticancer compounds5 Jun 2025US 2025/0179059 A1Poseidon Innovation, LLC
Most cited
By later US patents
- N-indanyl carboxamide derivative and agricultural/horticultural fungicide containing the derivative as active ingredient141US 4,914,097 AMitsubishi Kasei Corporation · 1990
- Aminoalkyl furan derivatives112US 4,128,658 AAllen & Hanburys Limited · 1978
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001
- Pharmacologically active guanidine compounds97US 3,950,333 ASmith Kline & French Laboratories Limited · 1976
- Isothiazole derivatives useful as anticancer agents91US 6,235,764 B1Pfizer Inc. · 2001